Assessment of Natural Killer Cells in Unexplained Recurrent Pregnancy Loss
1 other identifier
observational
60
1 country
1
Brief Summary
To assess natural killer cells frequency and activation in cases of unexplained recurrent abortion in comparison to fertile cases
- 2\. . To study the expression of stimulatory receptors of natural killer cell.
- 3-To study the expression of inhibitory receptors of natural killer cell.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 30, 2019
CompletedFirst Submitted
Initial submission to the registry
May 6, 2019
CompletedFirst Posted
Study publicly available on registry
May 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2020
CompletedMay 8, 2019
May 1, 2019
7 months
May 6, 2019
May 6, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
asses the number of Natural killer cells
flowcytometry
15 month
Study Arms (2)
unexplained recurrent pregnancy loss
peripheral blood sample examined by flowcytometry
control fertile multipara
peripheral blood sample examined by flowcytometry
Eligibility Criteria
We will recruit patients from outpatient clinics from Assuit University Hospital,Women fulfilling eligibility criteria will be included after careful gynecologycal examination,Those who consent to participate will be referred to the lab for investigation.
You may qualify if:
- Age less than 40 years. 2.History of two or more spontaneous miscarriages .
You may not qualify if:
- \. Age more than 35 years. 2. Women with elevated level of TSH above (2.5 mIU/ml) or prolactin above( 19.5 ng/mL)and uncontrolled DM.
- \. Women with autoimmune disorder (antiphospholipid antibody syndrome)with LA1/LA2 ratio more than( 1.2).
- Women receiving oral contraceptive pills.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yossra Mahmoud Mohammed
Asyut, 088, Egypt
Related Publications (1)
Fukui A, Kamoi M, Funamizu A, Fuchinoue K, Chiba H, Yokota M, Fukuhara R, Mizunuma H. NK cell abnormality and its treatment in women with reproductive failures such as recurrent pregnancy loss, implantation failures, preeclampsia, and pelvic endometriosis. Reprod Med Biol. 2015 Apr 11;14(4):151-157. doi: 10.1007/s12522-015-0207-7. eCollection 2015 Oct.
PMID: 29259412RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
assiut university
Assiut University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assesment of Natu
Study Record Dates
First Submitted
May 6, 2019
First Posted
May 8, 2019
Study Start
April 30, 2019
Primary Completion
December 1, 2019
Study Completion
July 20, 2020
Last Updated
May 8, 2019
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share